Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

Abstract

Transdermal fentanyl was preferred to sustained release oral morphine by patients with chronic non-cancer pain previously treated with opioids. The main reason for preference was better pain relief, achieved with less constipation and an enhanced quality of life.